Literature DB >> 12847075

Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barré syndrome.

Julia Wanschitz1, Hans Maier, Hans Lassmann, Herbert Budka, Thomas Berger.   

Abstract

Humoural and cellular immune mechanisms are involved in the pathogenesis of Guillain-Barré syndrome (GBS). While activation of complement has been implicated in the initiation of myelin damage, we provide data here on the role of cellular cytotoxicity in GBS. Archival autopsy tissues including spinal roots, dorsal root ganglia and peripheral nerve were examined from 11 subjects who died 1 day to 8 weeks after onset of symptoms from GBS exhibiting a primary demyelinating pathology. In order to study the extent of humoural and cellular immune processes with regard to disease duration, a broad panel of antibodies to immunological and cellular markers was used to visualize the stage of demyelination, the deposition of complement components and expression of CD59, and to characterize cell infiltrates. Deposits of C9neo antigen on degenerating myelin sheaths were predominantly detected in acute cases. Expression of CD59 was upregulated on demyelinating fibres, but did not correlate with the presence of C9neo antigen or duration of disease. Quantitative analysis of endoneurial T cells showed a correlation between the density of CD3+ T cells per square unit and the degree of demyelination, but not with the duration of disease. The ratio of CD8+ to CD3+ T cells, however, was significantly increased in cases of GBS with a subacute course. Granzyme B positive lymphocytes and upregulation of MHC class I molecules on Schwann cells and myelin sheaths were detected in cases with more than 4 weeks disease duration. These findings implicate an important role of cytotoxic T cell responses for myelin damage in subacute stages of GBS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12847075     DOI: 10.1093/brain/awg207

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  14 in total

1.  Pathogenesis and treatment of immune-mediated neuropathies.

Authors:  Helmar C Lehmann; Gerd Meyer Zu Horste; Bernd C Kieseier; Hans-Peter Hartung
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

Review 2.  Molecules involved in the crosstalk between immune- and peripheral nerve Schwann cells.

Authors:  Nevena Tzekova; André Heinen; Patrick Küry
Journal:  J Clin Immunol       Date:  2014-04-17       Impact factor: 8.317

3.  Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier.

Authors:  Jérôme J Devaux
Journal:  Am J Pathol       Date:  2012-08-10       Impact factor: 4.307

4.  Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies.

Authors:  Gerd Meyer Zu Horste; Holger Heidenreich; Helmar C Lehmann; Soldano Ferrone; Hans-Peter Hartung; Heinz Wiendl; Bernd C Kieseier
Journal:  Glia       Date:  2010-01-01       Impact factor: 7.452

5.  A new animal model of spontaneous autoimmune peripheral polyneuropathy: implications for Guillain-Barré syndrome.

Authors:  Mu Yang; Anthony Rainone; Xiang Qun Shi; Sylvie Fournier; Ji Zhang
Journal:  Acta Neuropathol Commun       Date:  2014-01-08       Impact factor: 7.801

Review 6.  Novel pathomechanisms in inflammatory neuropathies.

Authors:  David Schafflick; Bernd C Kieseier; Heinz Wiendl; Gerd Meyer Zu Horste
Journal:  J Neuroinflammation       Date:  2017-11-28       Impact factor: 8.322

Review 7.  Neuro-glial interactions at the nodes of Ranvier: implication in health and diseases.

Authors:  Catherine Faivre-Sarrailh; Jérôme J Devaux
Journal:  Front Cell Neurosci       Date:  2013-10-29       Impact factor: 5.505

Review 8.  Evidence from Human and Animal Studies: Pathological Roles of CD8(+) T Cells in Autoimmune Peripheral Neuropathies.

Authors:  Mu Yang; Corentin Peyret; Xiang Qun Shi; Nicolas Siron; Jeong Ho Jang; Sonia Wu; Sylvie Fournier; Ji Zhang
Journal:  Front Immunol       Date:  2015-10-15       Impact factor: 7.561

9.  Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes.

Authors:  Angela Orcurto; Andreas Hottinger; Benita Wolf; Blanca Navarro Rodrigo; Maria Ochoa de Olza; Aymeric Auger; Thierry Kuntzer; Denis Comte; Virginie Zimmer; Philippe Gannon; Lana Kandalaft; Olivier Michielin; Stefan Zimmermann; Alexandre Harari; Lionel Trueb; George Coukos
Journal:  J Immunother Cancer       Date:  2020-08       Impact factor: 13.751

Review 10.  Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma.

Authors:  Wendy Anne Boivin; Dawn Michelle Cooper; Paul Ryan Hiebert; David James Granville
Journal:  Lab Invest       Date:  2009-09-21       Impact factor: 5.502

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.